Health
Hematopoietic stem cell transplants may provide long-term benefit for people with MS – EurekAlert
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS)…
MINNEAPOLIS – A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after…
-
Noosa News23 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General22 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General19 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General12 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore